On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
We, the undersigned civil society organisations in Africa, hereby call upon the Bill and Melinda Gates Foundation and the Target Malaria project to stop the intended release of 10 000 genetically modified (GM) “male sterile” mosquitoes in Burkina Faso, as the release poses unacceptable risks to human beings and the environment.
A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil.
Press Release issued by African Centre for Biodiversity, Third World Network and GeneWatch UK
Johannesburg, 9 November 2018
Release of risky GM mosquitoes in Burkina Faso highly unethical
Press Release from the African Centre for Biodiversity
AU’s premature and misguided endorsement of controversial, unproven gene drive mosquitos for malaria ‘eradication’ in Africa
Johannesburg, Monday, 5 November 2018
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.
In this briefing paper ACB, TWN and GeneWatch UK discuss that genetically modified (GM) mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016. They are currently in “contained use” facilities in Bobo-Dioulasso, and are being used in experiments by a research consortium called Target Malaria.